context

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 76/100

   Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review

   ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-12-01 · Cognitive tests and assessment

   Digital cognitive assessments have rapidly expanded in Alzheimer's disease (AD) research, offering a sensitive, scalable, and cost-effective alternative to traditional neuropsychological tests.

   • Early Stage
   • Digital Tools
2. 59/100

   Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

   ✓ Peer-reviewed alzhub usefulness score 59 out of 100. European journal of nuclear medicine and molecular imaging · 2021-02-16 · Brain scans and imaging

   The current literature provides overall preliminary evidence on the establishment of the second-generation tau PET tracers into the clinical context, thereby successfully addressing some methodological issues from the tau PET tracer of the first generation.

   • Brain Scans
   • Biomarkers
3. 43/100

   Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. European journal of nuclear medicine and molecular imaging · 2021-02-06 · Brain scans and imaging

   Current literature provides partial evidence for clinical utility of [ 18 F]flortaucipir PET.

   • Brain Scans
   • Clinical Trials
   • Biomarkers

All topic tags with their study counts